Trinity Biotech Plc (TRIB)
7.00
+1.23
(+21.32%)
USD |
NASDAQ |
Oct 06, 16:00
6.00
-1.00
(-14.29%)
After-Hours: 20:00
Trinity Biotech Free Cash Flow : -12.50M for Dec. 31, 2025
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2025 | -12.50M |
| September 30, 2025 | -9.605M |
| June 30, 2025 | -16.59M |
| March 31, 2025 | -19.17M |
| December 31, 2024 | -20.51M |
| September 30, 2024 | -22.91M |
| June 30, 2024 | -21.53M |
| March 31, 2024 | -22.18M |
| December 31, 2023 | -21.88M |
| September 30, 2023 | -20.56M |
| June 30, 2023 | -15.76M |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 8.394M |
| September 30, 2021 | 15.39M |
| June 30, 2021 | 22.80M |
| March 31, 2021 | 24.34M |
| December 31, 2020 | 19.76M |
| September 30, 2020 | 3.648M |
| June 30, 2020 | 1.25M |
| March 31, 2020 | -0.105M |
| December 31, 2019 | 1.421M |
| Date | Value |
|---|---|
| September 30, 2019 | 8.985M |
| June 30, 2019 | 6.955M |
| March 31, 2019 | 4.971M |
| December 31, 2018 | 2.726M |
| September 30, 2018 | 2.004M |
| June 30, 2018 | 3.472M |
| March 31, 2018 | 5.197M |
| December 31, 2017 | 4.65M |
| September 30, 2017 | 1.847M |
| June 30, 2017 | 5.462M |
| March 31, 2017 | 4.226M |
| December 31, 2016 | 5.624M |
| September 30, 2016 | 14.94M |
| June 30, 2016 | 10.85M |
| March 31, 2016 | 10.93M |
| December 31, 2015 | 10.95M |
| September 30, 2015 | 13.96M |
| June 30, 2015 | 15.53M |
| March 31, 2015 | 16.73M |
| December 31, 2014 | 15.88M |
| September 30, 2014 | 7.536M |
| June 30, 2014 | 5.804M |
| March 31, 2014 | 7.089M |
| December 31, 2013 | -13.80M |
| September 30, 2013 | 6.097M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| DBV Technologies SA | -152.18M |
| Cellectis SA | -45.36M |
| Akari Therapeutics Plc | -10.74M |
| Autolus Therapeutics Plc | -240.12M |
| Evaxion AS | -- |
Free Cash Flow Related Metrics
| Free Cash Flow Per Share (Quarterly) | -3.790 |
| Free Cash Flow to Equity (Quarterly) | -23.13M |
| Free Cash Flow to Firm (Quarterly) | 10.18M |
| Free Cash Flow Yield | -288.7% |